Comprehensive Proteomic Profiling of Aqueous Humor Proteins in Proliferative Diabetic Retinopathy.


Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
03 05 2021
Historique:
entrez: 10 6 2021
pubmed: 11 6 2021
medline: 29 6 2021
Statut: ppublish

Résumé

Proliferative diabetic retinopathy (PDR) is a serious ocular disease that can lead to retinal microvascular complications in patients with diabetes mellitus. To date, no studies have explored PDR development by analyzing the aqueous humor (AH). Therefore we carried out tandem mass tag (TMT) proteomic quantification to compare AH protein profiles between PDR and non-PDR subjects. We enrolled six PDR and six control (senile cataract) subjects. AH samples were collected during surgery and stored at -80°C. Proteins were extracted, trypsin-digested, and labeled with TMTs for mass spectrometric analysis. We found 191 proteins to be changed with |log2 (fold change)| ≥1 (P < 0.05 and identification with at least two peptides per protein). Of them, 111 were downregulated, whereas 80 were upregulated in the PDR group. Proteomic bioinformatic analysis indicated that PDR development was related to complement and coagulation cascades, platelet activation, extracellular matrix-receptor interaction, focal adhesion, protein digestion and absorption, human papillomavirus infection, PI3K-Akt signaling pathway, cholesterol metabolism, peroxisome proliferator-activated receptor signaling pathways, fat digestion and absorption, and vitamin digestion and absorption pathways. Comprehensive proteomic profiling of the AH revealed 191 differentially expressed proteins between the two groups. Most of these proteins belong to secretory pathways, and therefore can be used as biomarkers in clinical testing and basic research. Pathway analysis and a review of the literature enabled us to draw a novel biological map that will support further studies on the underlying mechanisms and therapeutic control of PDR development.

Identifiants

pubmed: 34111250
pii: 2772560
doi: 10.1167/tvst.10.6.3
pmc: PMC8107506
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3

Références

Prog Retin Eye Res. 2013 Jan;32:181-95
pubmed: 23128417
Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):26
pubmed: 32084272
Cell Tissue Res. 2020 Jul;381(1):177-187
pubmed: 32112256
Cell Physiol Biochem. 2017;43(3):1100-1112
pubmed: 28977794
J Proteome Res. 2015 Dec 4;14(12):5131-43
pubmed: 26490944
Anticancer Drugs. 1996 Sep;7(7):723-7
pubmed: 8949981
BMC Ophthalmol. 2018 Jun 26;18(1):151
pubmed: 29940965
Exp Clin Endocrinol Diabetes. 2016 May;124(5):263-75
pubmed: 27219686
Int Ophthalmol. 2020 Oct;40(10):2763-2769
pubmed: 32556740
Ophthalmic Epidemiol. 2020 Oct;27(5):384-389
pubmed: 32374640
Biochem J. 2018 Apr 5;475(7):1253-1265
pubmed: 29523748
J R Soc Med. 2003 Jun;96(6):266-72
pubmed: 12782689
Int J Mol Sci. 2019 Oct 02;20(19):
pubmed: 31581657
Can J Diabetes. 2020 Jul;44(5):414-421
pubmed: 32205075
Electrophoresis. 2014 Sep;35(17):2495-508
pubmed: 24825767
Pharmacol Ther. 2014 May;142(2):164-75
pubmed: 24333502
Acta Ophthalmol. 2016 Feb;94(1):56-64
pubmed: 26268591
Metabolism. 2018 Oct;87:36-47
pubmed: 29928895
Proteomics Insights. 2017 Mar 15;8:1178641816686078
pubmed: 28469465
Int J Mol Sci. 2020 Feb 13;21(4):
pubmed: 32070055
J Proteomics. 2012 Jun 6;75(10):2950-9
pubmed: 22200677
Mol Cell Proteomics. 2019 Jul;18(7):1468-1478
pubmed: 30967486
Curr Eye Res. 2012 Sep;37(9):803-8
pubmed: 22563689
Int J Mol Sci. 2018 Nov 18;19(11):
pubmed: 30453687
Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD31-AMD40
pubmed: 30025106
Int J Mol Sci. 2019 Aug 29;20(17):
pubmed: 31470605

Auteurs

Hu Xiao (H)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
The 7th Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong Province, China.

Wen Xin (W)

The 7th Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong Province, China.

Li Mei Sun (LM)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Song Shan Li (SS)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Ting Zhang (T)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Xiao Yan Ding (XY)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH